0939-6411
Bimonthly
No
EUR J PHARM BIOPHARM
1991
262
NETHERLANDS
http://www.elsevier.com/wps/find/journaldescription.cws_home/600120/description
約3.0個(gè)月審稿時(shí)間
66%平均錄用比例
4.708影響因子
藥學(xué)小學(xué)科
月期刊平臺(tái)服務(wù)過的文章錄用時(shí)間為1-3個(gè)月,依據(jù)20年經(jīng)驗(yàn),經(jīng)月期刊專家預(yù)審?fù)ㄟ^后的文章,投稿通過率100%以上!
《歐洲藥學(xué)和生物藥理學(xué)雜志》提供了一個(gè)出版來(lái)自制藥技術(shù)、制藥生物技術(shù)和生物藥理學(xué)領(lǐng)域的新穎和創(chuàng)新研究的媒體。主題包括:?藥物和藥物前設(shè)計(jì)、藥物穩(wěn)定性和藥物開發(fā)?藥物和生物制藥的開發(fā)、配方和制造?物理制藥、藥物傳遞系統(tǒng)、控制釋放系統(tǒng)和藥物靶向?生物藥劑學(xué)?藥物分析和藥物包裝?質(zhì)量控制、GMP和法規(guī)方面?醫(yī)療設(shè)備“三的規(guī)則”編輯和編輯委員會(huì)制定了“3的規(guī)則”。在投稿前,作者必須考慮以下三個(gè)標(biāo)準(zhǔn),并在工作中設(shè)定完整的編輯審核流程:1. 這篇論文必須報(bào)道在制藥技術(shù)、生物制藥和重要的制藥生物技術(shù)方面的最新進(jìn)展2. 一篇論文必須基于深入和廣泛的研究,使用已建立的或描述良好的方法,包括適當(dāng)?shù)目刂?。研究必須是假設(shè)驅(qū)動(dòng)的,結(jié)論必須得到數(shù)據(jù)的支持。3.手稿中描述的研究必須代表一種新穎的方法這些規(guī)則也被用作同行審稿的指導(dǎo)方針。請(qǐng)按此瀏覽“規(guī)則三”
http://ees.elsevier.com/ejpb/
The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.Topics covered include:? Drug and pro-drug design, drug stability and drug development? Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals? Physical pharmacy, drug delivery systems, controlled release systems and drug targeting? Biopharmaceutics? Pharmaceutical analysis and pharmaceutical packaging? Quality control, GMP and regulatory aspects? Medical devices"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:1. The paper must report on recent advances in pharmaceutical technology, biopharmaceutics and pharmaceutical biotechnology of major importance2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.3. The study described in the manuscript must represent a novel approachThe rules are also used as guidelines for the peer review of manuscripts. CLICK HERE to view the "Rules of 3".
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢校對(duì)編輯、深度潤(rùn)色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語(yǔ)句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢數(shù)據(jù)庫(kù)包括:期刊、文章、書籍、會(huì)議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA PHARMACEUTICA | 醫(yī)學(xué) | 藥學(xué) | 1.405 | N/A | 1330-0075 |
ACTA POLONIAE PHARMACEUTICA | 醫(yī)學(xué) | 藥學(xué) | 0.447 | N/A | 0001-6837 |
ADVANCED DRUG DELIVERY REVIEWS | 醫(yī)學(xué) | 藥學(xué) | 15.519 | N/A | 0169-409X |
ALCOHOL | 醫(yī)學(xué) | 藥學(xué) | 2.039 | N/A | 0741-8329 |
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 醫(yī)學(xué) | 藥學(xué) | 2.012 | N/A | 1079-2082 |
AMERICAN JOURNAL OF THERAPEUTICS | 醫(yī)學(xué) | 藥學(xué) | 1.133 | N/A | 1075-2765 |
ANNALS OF PHARMACOTHERAPY | 醫(yī)學(xué) | 藥學(xué) | 2.443 | N/A | 1060-0280 |
Annual Review of Pharmacology and Toxicology | 醫(yī)學(xué) | 藥學(xué) | 12.103 | N/A | 0362-1642 |
ANTIVIRAL RESEARCH | 醫(yī)學(xué) | 藥學(xué) | 4.13 | 2區(qū) | 0166-3542 |
Bangladesh Journal of Pharmacology | 醫(yī)學(xué) | 藥學(xué) | 0.811 | N/A | 1991-007X |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊